Ali Mortezaei
@alimortezaei.bsky.social
Learner | SoMe Editor @JNeurooncol @INR_WFITN @TheNeuroradJour | Resraecher @monteinsteincrl | Aspiring #Neurosurgeon | Fan of @lakers @realmadrid
Pinned
Hello, Blue Sky!
I'm Ali Mortezaei, a final-year medical student in Iran with a strong focus on #cerebrovascular diseases, #neuro-oncology, and #spine research. Passionate about advancing #neurosurgery, I'm eager to connect with this great community.
Looking forward to learning and growing together!
I'm Ali Mortezaei, a final-year medical student in Iran with a strong focus on #cerebrovascular diseases, #neuro-oncology, and #spine research. Passionate about advancing #neurosurgery, I'm eager to connect with this great community.
Looking forward to learning and growing together!
🚨Hot of press!
Every second counts in stroke care! ⏱️ Direct transfer to angiosuite (DTAS) is safe & effective compared to conventional triage for LVO strokes.
Special thanks to team and mentors for great work.
Read more:https://www.sciencedirect.com/science/article/pii/S0967586825000827
Every second counts in stroke care! ⏱️ Direct transfer to angiosuite (DTAS) is safe & effective compared to conventional triage for LVO strokes.
Special thanks to team and mentors for great work.
Read more:https://www.sciencedirect.com/science/article/pii/S0967586825000827
February 8, 2025 at 5:45 PM
🚨Hot of press!
Every second counts in stroke care! ⏱️ Direct transfer to angiosuite (DTAS) is safe & effective compared to conventional triage for LVO strokes.
Special thanks to team and mentors for great work.
Read more:https://www.sciencedirect.com/science/article/pii/S0967586825000827
Every second counts in stroke care! ⏱️ Direct transfer to angiosuite (DTAS) is safe & effective compared to conventional triage for LVO strokes.
Special thanks to team and mentors for great work.
Read more:https://www.sciencedirect.com/science/article/pii/S0967586825000827
Reposted by Ali Mortezaei
FDA Released Draft Guidance on Incorporating Tissue Biopsies in Clinical Trials
@fda.gov
oncodaily.com/insight/fda2...
#Cancer #FDA #OncoDaily #Oncology #TissueBiopsy #Medicine #Health
@fda.gov
oncodaily.com/insight/fda2...
#Cancer #FDA #OncoDaily #Oncology #TissueBiopsy #Medicine #Health
FDA Released Draft Guidance on Incorporating Tissue Biopsies in Clinical Trials - OncoDaily
FDA Released Draft Guidance on Incorporating Tissue Biopsies in Clinical Trials / cancer, FDA, OncoDaily, Oncology, Richard Pazdur, tissue biopsy
oncodaily.com
January 11, 2025 at 4:18 PM
FDA Released Draft Guidance on Incorporating Tissue Biopsies in Clinical Trials
@fda.gov
oncodaily.com/insight/fda2...
#Cancer #FDA #OncoDaily #Oncology #TissueBiopsy #Medicine #Health
@fda.gov
oncodaily.com/insight/fda2...
#Cancer #FDA #OncoDaily #Oncology #TissueBiopsy #Medicine #Health
Grateful to have our work at Journal of Neuro-Oncology featured by @oncodaily.bsky.social.
Special thanks to Dr. Jason Sheehan and Dr. Amir Faraji for their support and team for their great work.
#Neuro-Oncology #Neurosurgery
oncodaily.com/insight/jaso...
Special thanks to Dr. Jason Sheehan and Dr. Amir Faraji for their support and team for their great work.
#Neuro-Oncology #Neurosurgery
oncodaily.com/insight/jaso...
Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management - OncoDaily
Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management / Ali Mohammad Mokhtari, Ali Mortezaei, Ali Motamed-Sanaye, Amir Afshari, Amir
oncodaily.com
January 3, 2025 at 2:16 PM
Grateful to have our work at Journal of Neuro-Oncology featured by @oncodaily.bsky.social.
Special thanks to Dr. Jason Sheehan and Dr. Amir Faraji for their support and team for their great work.
#Neuro-Oncology #Neurosurgery
oncodaily.com/insight/jaso...
Special thanks to Dr. Jason Sheehan and Dr. Amir Faraji for their support and team for their great work.
#Neuro-Oncology #Neurosurgery
oncodaily.com/insight/jaso...
Hello, Blue Sky!
I'm Ali Mortezaei, a final-year medical student in Iran with a strong focus on #cerebrovascular diseases, #neuro-oncology, and #spine research. Passionate about advancing #neurosurgery, I'm eager to connect with this great community.
Looking forward to learning and growing together!
I'm Ali Mortezaei, a final-year medical student in Iran with a strong focus on #cerebrovascular diseases, #neuro-oncology, and #spine research. Passionate about advancing #neurosurgery, I'm eager to connect with this great community.
Looking forward to learning and growing together!
January 3, 2025 at 9:31 AM
Hello, Blue Sky!
I'm Ali Mortezaei, a final-year medical student in Iran with a strong focus on #cerebrovascular diseases, #neuro-oncology, and #spine research. Passionate about advancing #neurosurgery, I'm eager to connect with this great community.
Looking forward to learning and growing together!
I'm Ali Mortezaei, a final-year medical student in Iran with a strong focus on #cerebrovascular diseases, #neuro-oncology, and #spine research. Passionate about advancing #neurosurgery, I'm eager to connect with this great community.
Looking forward to learning and growing together!
Reposted by Ali Mortezaei
The NEJM Group 2024 Notable Articles collection is out - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/insight/vive...
#Cancer #NEJM #NotableArticles #OncoDaily #Oncology #Medicine #Health
@viveksubbiah.bsky.social
oncodaily.com/insight/vive...
#Cancer #NEJM #NotableArticles #OncoDaily #Oncology #Medicine #Health
Vivek Subbiah: The NEJM Group 2024 Notable Articles collection is out - OncoDaily
Vivek Subbiah: The NEJM Group 2024 Notable Articles collection is out / cancer, NEJM, New England Journal of Medicine, Notable Articles, OncoDaily, Oncology,
oncodaily.com
January 2, 2025 at 5:37 PM
The NEJM Group 2024 Notable Articles collection is out - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/insight/vive...
#Cancer #NEJM #NotableArticles #OncoDaily #Oncology #Medicine #Health
@viveksubbiah.bsky.social
oncodaily.com/insight/vive...
#Cancer #NEJM #NotableArticles #OncoDaily #Oncology #Medicine #Health